Healthcare -
Biotechnology - NASDAQ - GB
$ 10.505
-2.19 %
$ 7.5 B
Market Cap
-10.5
P/E
ROIV - REVENUE
Revenue ROIV - Roivant Sciences Ltd.
125 M
LAST VALUE
50.24%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR